Lombard Odier Asset Management (Switzerland) Sa Editas Medicine, Inc. Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.27 Billion
Q4 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$12.16 - $19.42 $213,821 - $341,481	-17,584 Reduced 6.77%	242,248 $2.97 Million
Q2 2022 Aug 15, 2022	SELL	$9.99 - $21.35 $1.21 Million - $2.59 Million	-121,131 Reduced 31.8%	259,832 $3.07 Million
Q1 2022 May 16, 2022	BUY	$14.08 - $27.63 $952,385 - $1.87 Million	67,641 Added 21.59%	380,963 $7.25 Million
Q4 2021 Feb 14, 2022	BUY	$26.55 - $40.57 $2.78 Million - $4.25 Million	104,818 Added 50.27%	313,322 $8.32 Million
Q3 2021 Nov 12, 2021	SELL	$39.27 - $72.94 $3.72 Million - $6.9 Million	-94,629 Reduced 31.22%	208,504 $8.57 Million
Q2 2021 Aug 13, 2021	BUY	$31.29 - $56.64 $3.57 Million - $6.45 Million	113,939 Added 60.22%	303,133 $17.2 Million
Q1 2021 May 17, 2021	BUY	$39.71 - $90.58 $7.51 Million - $17.1 Million	189,194 New	189,194 $7.95 Million

Others Institutions Holding EDIT

# of Institutions

225

Shares Held

54.2M

Call Options Held

412K

Put Options Held

355K

Black Rock Inc. New York, NY

7.78M
Shares

$14.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.82M
Shares

$13.1 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.75M
Shares

$5.27 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.16M
Shares

$4.15 Million
0.0% of portfolio
State Street Corp Boston, MA

1.87M
Shares

$3.59 Million
0.0% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $132M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account